Skip to content
10-Q

Quarterly Report

SIERRA ONCOLOGY, INC.

0001564590-22-018449

← back to feed
Filed
May 6, 2022 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2022 · May 2, 2022 24.42M sh
Capex Q1 2022 · Mar 31, 2022 $62K
Operating Cash Flow Q1 2022 · Mar 31, 2022 −$25.74M
Operating Cash Flow Q1 2022 · Mar 31, 2021 −$16.96M
Long Term Debt Q1 2022 · Mar 31, 2022 $4.86M
Cash And Equivalents Q1 2022 · Mar 31, 2022 $274.02M
Cash And Equivalents Q1 2022 · Dec 31, 2021 $104.75M
Cash And Equivalents Q1 2022 · Mar 31, 2021 $107.66M
Stockholders Equity Q1 2022 · Mar 31, 2022 $261.62M
Stockholders Equity Q1 2022 · Dec 31, 2021 $96M
Stockholders Equity Q1 2022 · Mar 31, 2021 $101.56M
Stockholders Equity Q1 2022 · Dec 31, 2020 $97.96M
Current Liabilities Q1 2022 · Mar 31, 2022 $13.08M
Current Liabilities Q1 2022 · Dec 31, 2021 $12.88M
Total Liabilities Q1 2022 · Mar 31, 2022 $18.38M
Total Liabilities Q1 2022 · Dec 31, 2021 $13.37M
Current Assets Q1 2022 · Mar 31, 2022 $278.2M
Current Assets Q1 2022 · Dec 31, 2021 $107.39M
Total Assets Q1 2022 · Mar 31, 2022 $280M
Total Assets Q1 2022 · Dec 31, 2021 $109.37M
Sga Expense Q1 2022 · Mar 31, 2022 $10.33M
Sga Expense Q1 2022 · Mar 31, 2021 $5.87M
Rd Expense Q1 2022 · Mar 31, 2022 $17.55M
Rd Expense Q1 2022 · Mar 31, 2021 $13.95M
Net Income Q1 2022 · Mar 31, 2022 −$27.93M
Net Income Q1 2022 · Mar 31, 2021 −$19.92M
Operating Income Q1 2022 · Mar 31, 2022 −$27.88M
Operating Income Q1 2022 · Mar 31, 2021 −$19.82M